MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    DJ-1 (PARK7) Heterozygous Mutation and Early-Onset Parkinson’s Disease: A Chilean Case Report and Literature Review

    K. Guzmán, M. Sanchez, D. Avila (Santiago de Chile, Chile)

    Objective: We report a Chilean patient with childhood-onset Parkinson’s disease (PD) carrying a single heterozygous PARK7 (DJ-1) mutation and review its clinical and pathophysiological relevance.…
  • 2026 International Congress

    Effect of ApoE ε4 allele on brain metabolism and cognition in non-demented Parkinson’s disease

    JH. Lee, YH. Ryu, CH. Lyoo, HS. Yoo (Seoul, Republic of Korea)

    Objective: This study aimed to explore the interplay between Apolipoprotein E (ApoE) ε4 allele, brain metabolism, and cognition in non-demented Parkinson’s disease (PD) patients. Background:…
  • 2026 International Congress

    Standardised Home-Based Walk Tests Can Capture Gait Differences in Parkinson’s Disease Using Wearable Sensors

    C. Sotirakis, N. Conway, J. Ren, M. Dockendorf, O. Patil, S. Lee, J. Fitzgerald, C. Antoniades (University of Oxford, United Kingdom)

    Objective: To evaluate the feasibility and discriminative utility of a standardised home-based walk test using wearable sensors in people with Parkinson's disease (PwP). Background: Wearable…
  • 2026 International Congress

    Characterisation of early onset Parkinson’s disease in UK cohorts

    E. Lam, J. Frost, M. Fenn, S. Jasaityte, N. Kuznetsov, L. Lange, D. Vitale, D. Grosset, N. Williams, R. Real, H. Morris (London, United Kingdom)

    Objective: To identify and describe the genetic features of UK early onset Parkinson’s disease (EOPD) patients. Background: EOPD with age of onset (AAO) <36 years…
  • 2026 International Congress

    Fibrinogen and CFAH as putative biomarkers for Parkinson’s disease

    P. Alladi, S. Choudhury, R. Bhavani, NC. Krithika, K. Krishnakumari, H. Jyothi, A. Mahadevan, P. Pal, V. Holla, S. Hegde, N. Kamble, R. Yadav (Bengaluru, India)

    Objective: To examine the levels of putative biomarkers FIB, CFAH, gelsolin (GSN), α-syn and phosphorylated-α-syn in PD serum. To localize and quantify FIB and CFAH in…
  • 2026 International Congress

    Segment-Level Gait Dynamics Reveal Parkinsonian Motor Signatures in Fall-Prone Older Adults Using Multi-Channel Time–Frequency Deep Learning

    B. Kim, C. Youm, J. Hwang, M. Kim, S. Cheon (Busan, Republic of Korea)

    Objective: To develop a multi-channel time–frequency deep learning framework capable of identifying Parkinsonian gait dynamics from short locomotor segments and detecting PD-like motor state transitions…
  • 2026 International Congress

    Sex Differences in Prodromal Features of Parkinson’s Disease: Evidence from Large Multi-Centre Cohorts

    M. Tan, Y. Zaplatnikov, K. Atterling-Brolin, S. Jónsdóttir, S. Schnell, R. Krüger, W. Poewe, P. Mahlknecht, E. Tolosa, M. Marti, V. Satagopam, C. Trenkwalder, L. Smith, C. Horlings, A. Noyce (Oslo, Norway)

    Objective: To explore sex differences in symptoms of prodromal Parkinson’s disease (PD) in large, population-based multi-centre cohorts of healthy individuals, PREDICT-PD and Healthy Brain Ageing…
  • 2026 International Congress

    Clinical instability and fluctuations as an early marker of accelerated progression

    A. Beltrán-Torres, M. Rocha-de-León, K. Sánchez-Ramírez, N. Sánchez-Lorenzo, A. Cervantes-Arriaga, M. Rodríguez-Violante (Monterrey, Mexico)

    Objective: To determine whether early clinical instability, quantified through combined motor and non-motor fluctuations, predicts a more severe longitudinal disease course in Parkinson’s disease. Background:…
  • 2026 International Congress

    Does Knowing More Mean Tolerating More? Satisfaction with Medication Information and Levodopa Dosage in Parkinson’s Disease

    M. da Silva, M. Tosin, L. Silveira-Moriyama (Campinas, Brazil)

    Objective: To characterize the correlation between satisfaction with medication-related information and daily levodopa dosage in Parkinson’s disease (PD) patients presenting with levodopa-related complaints. Background: Adequate…
  • 2026 International Congress

    Impulse-compulsive disorders and non-motor symptom profiles in Parkinson’s disease: findings from a Tunisian cohort

    E. Cherif, A. Rekik, A. Mili, K. Jemai, A. Hsini, H. Slimen, S. Naija, A. Hassine, S. Ben Amor (Sousse, Tunisia)

    Objective: To examine the relationship between impulse-compulsive disorders (ICDs) and non-motor symptom profiles in patients with Parkinson’s disease (PD). Background: ICDs are recognized non-motor complications…
  • « Previous Page
  • 1
  • …
  • 84
  • 85
  • 86
  • 87
  • 88
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley